Skip to content
November 1, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Kanker Payudara

Kanker Payudara

Primary Menu
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Watch
Cadence’s HypertensionOS Selected for Landmark FDA Digital Health Pilot: A New Era for AI-Driven Chronic Care cadences-hypertensionos-selected-for-landmark-fda-digital-health-pilot-a-new-era-for-ai-driven-chronic-care
  • Treatment Innovations

Cadence’s HypertensionOS Selected for Landmark FDA Digital Health Pilot: A New Era for AI-Driven Chronic Care

Jia Lissa August 17, 2026
In a significant move toward the modernization of chronic disease management, the US Food and Drug Administration...
Read More Read more about Cadence’s HypertensionOS Selected for Landmark FDA Digital Health Pilot: A New Era for AI-Driven Chronic Care
A New Era of Global Health Solidarity: Luxembourg and the WHO Seal Landmark €47.5 Million Partnership a-new-era-of-global-health-solidarity-luxembourg-and-the-who-seal-landmark-e47-5-million-partnership
  • Breast Cancer Prevention and Lifestyle

A New Era of Global Health Solidarity: Luxembourg and the WHO Seal Landmark €47.5 Million Partnership

Basiran August 17, 2026
By International Affairs Correspondent In a defining moment for international cooperation, the Grand Duchy of Luxembourg and...
Read More Read more about A New Era of Global Health Solidarity: Luxembourg and the WHO Seal Landmark €47.5 Million Partnership
A New Horizon in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer a-new-horizon-in-oncology-fda-approves-sacituzumab-govitecan-for-metastatic-triple-negative-breast-cancer
  • Patient Advocacy and Support

A New Horizon in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer

Laily UPN August 17, 2026
The landscape of breast cancer treatment has undergone a seismic shift following the U.S. Food and Drug...
Read More Read more about A New Horizon in Oncology: FDA Approves Sacituzumab Govitecan for Metastatic Triple-Negative Breast Cancer
A Fractured Alliance: The Geopolitical and Public Health Implications of the U.S. Withdrawal from the WHO a-fractured-alliance-the-geopolitical-and-public-health-implications-of-the-u-s-withdrawal-from-the-who
  • Global Breast Cancer Awareness

A Fractured Alliance: The Geopolitical and Public Health Implications of the U.S. Withdrawal from the WHO

Nana Wu August 17, 2026
Introduction: A Historic Divergence The announcement by the United States of its intent to withdraw from the...
Read More Read more about A Fractured Alliance: The Geopolitical and Public Health Implications of the U.S. Withdrawal from the WHO
Navigating the Unthinkable: How to Talk to Your Children About Cancer Recurrence navigating-the-unthinkable-how-to-talk-to-your-children-about-cancer-recurrence-1
  • Survivorship and Post-Treatment

Navigating the Unthinkable: How to Talk to Your Children About Cancer Recurrence

Pevita Pearce August 17, 2026
By Kelsey Mora, CCLS, LCPC Chief Clinical Officer at Pickles Group Hearing that cancer has returned is...
Read More Read more about Navigating the Unthinkable: How to Talk to Your Children About Cancer Recurrence
AI Breakthrough: A Single Genomic Test Could End the ‘Diagnostic Odyssey’ for Rare Diseases ai-breakthrough-a-single-genomic-test-could-end-the-diagnostic-odyssey-for-rare-diseases-1
  • Genomics and Precision Medicine

AI Breakthrough: A Single Genomic Test Could End the ‘Diagnostic Odyssey’ for Rare Diseases

Ali Ikhwan August 17, 2026
For thousands of families navigating the healthcare system, the search for a diagnosis for a child with...
Read More Read more about AI Breakthrough: A Single Genomic Test Could End the ‘Diagnostic Odyssey’ for Rare Diseases
AstraZeneca Navigates Complex Lung Cancer Landscape: Volrustomig Trial Discontinued Amidst Promising Data for Other Oncology Assets astrazeneca-navigates-complex-lung-cancer-landscape-volrustomig-trial-discontinued-amidst-promising-data-for-other-oncology-assets
  • Medical Research and Clinical Trials

AstraZeneca Navigates Complex Lung Cancer Landscape: Volrustomig Trial Discontinued Amidst Promising Data for Other Oncology Assets

Raul Delapena Setiawan August 17, 2026
London, UK – [Date of Publication] – In a significant development within the fiercely competitive oncology landscape,...
Read More Read more about AstraZeneca Navigates Complex Lung Cancer Landscape: Volrustomig Trial Discontinued Amidst Promising Data for Other Oncology Assets
Finding Light in the Aftermath: How One Person’s Journey of Grief and Identity Redefined the Meaning of Pride finding-light-in-the-aftermath-how-one-persons-journey-of-grief-and-identity-redefined-the-meaning-of-pride
  • Integrative Oncology and Holistic Care

Finding Light in the Aftermath: How One Person’s Journey of Grief and Identity Redefined the Meaning of Pride

Raul Delapena Setiawan August 17, 2026
For many, the month of June is synonymous with vibrant parades, rainbow flags, and boisterous celebrations of...
Read More Read more about Finding Light in the Aftermath: How One Person’s Journey of Grief and Identity Redefined the Meaning of Pride
The New Landscape of American Global Health: A Comprehensive Analysis of the Administration’s Foreign Assistance Overhaul the-new-landscape-of-american-global-health-a-comprehensive-analysis-of-the-administrations-foreign-assistance-overhaul
  • Breast Cancer Legislation and Policy

The New Landscape of American Global Health: A Comprehensive Analysis of the Administration’s Foreign Assistance Overhaul

Lina Hope August 17, 2026
Editorial Note: Originally published in May 2025, this resource has been updated to reflect the evolving legal...
Read More Read more about The New Landscape of American Global Health: A Comprehensive Analysis of the Administration’s Foreign Assistance Overhaul
Frontline Advocacy and the Future of Research: Dr. Kelly Shanahan Outlines Strategic Vision for 2026 Grant Cycle frontline-advocacy-and-the-future-of-research-dr-kelly-shanahan-outlines-strategic-vision-for-2026-grant-cycle
  • Patient Advocacy and Support

Frontline Advocacy and the Future of Research: Dr. Kelly Shanahan Outlines Strategic Vision for 2026 Grant Cycle

Lina Hope August 17, 2026
Introduction: Main Facts In a recent communication that bridges the gap between executive leadership and the lived...
Read More Read more about Frontline Advocacy and the Future of Research: Dr. Kelly Shanahan Outlines Strategic Vision for 2026 Grant Cycle

Posts pagination

Previous 1 … 389 390 391 392 393 394 395 … 847 Next

Recent Posts

  • A Paradigm Shift in Cancer Immunology: Unraveling the Enigma of Treg Cells in Colorectal Cancer
  • Sobi’s Pozdeutinurad Shows Significant Promise in Uncontrolled Gout After Positive Phase III Readout
  • A Survivor’s Unwavering Spirit: Navigating the Labyrinth of Breast Cancer with Hope and Resilience
  • The Architect of Oncology Data: Lori Swain’s Quarter-Century Legacy at the National Cancer Registrars Association
  • New Hope for Breast Cancer Survivors: Nutritional Supplement Shows Promise in Combating ‘Chemo Brain’

Recent Comments

No comments to show.

Archives

  • November 2026
  • October 2026
  • September 2026
  • August 2026
  • July 2026
  • June 2026
  • May 2026
  • September 2025
  • August 2025
  • July 2025

Categories

  • Breast Cancer Legislation and Policy
  • Breast Cancer Prevention and Lifestyle
  • Breast Cancer Surgery and Reconstruction
  • Chemotherapy and Targeted Therapy
  • Clinical Oncology Education
  • Clinical Radiology and Imaging
  • Genomics and Precision Medicine
  • Global Breast Cancer Awareness
  • Hormone Therapy and Endocrinology
  • Integrative Oncology and Holistic Care
  • Medical Research and Clinical Trials
  • Metastatic Breast Cancer Research
  • Patient Advocacy and Support
  • Psychosocial Support and Mental Health
  • Radiation Oncology
  • Survivorship and Post-Treatment
  • Treatment Innovations

You may have missed

a-paradigm-shift-in-cancer-immunology-unraveling-the-enigma-of-treg-cells-in-colorectal-cancer
  • Medical Research and Clinical Trials

A Paradigm Shift in Cancer Immunology: Unraveling the Enigma of Treg Cells in Colorectal Cancer

Muslim November 1, 2026
sobis-pozdeutinurad-shows-significant-promise-in-uncontrolled-gout-after-positive-phase-iii-readout
  • Medical Research and Clinical Trials

Sobi’s Pozdeutinurad Shows Significant Promise in Uncontrolled Gout After Positive Phase III Readout

Basiran November 1, 2026
a-survivors-unwavering-spirit-navigating-the-labyrinth-of-breast-cancer-with-hope-and-resilience
  • Patient Advocacy and Support

A Survivor’s Unwavering Spirit: Navigating the Labyrinth of Breast Cancer with Hope and Resilience

Ali Ikhwan November 1, 2026
the-architect-of-oncology-data-lori-swains-quarter-century-legacy-at-the-national-cancer-registrars-association
  • Patient Advocacy and Support

The Architect of Oncology Data: Lori Swain’s Quarter-Century Legacy at the National Cancer Registrars Association

Muslim November 1, 2026
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
  • Home
  • About Us
  • Contact Us
  • Cookies
  • Disclaimer
  • DMCA
  • Privacy Policy
  • TOS
Copyright © All rights reserved. | MoreNews by AF themes.